A 5 kg/m2 increase in BMI may correspond to approximately twofold increase in serum FGF21 levels, as calculated by the regression equation (S1 Table), suggesting that the chronic high level of blood FGF21 may have adverse effects on metabolic disease risk, as seen in healthy subjects [15, 21, 25]. Here, FGF21 is linked to Other metabolic disease.